Showing results (1-10 of 426) with videos related to
Sort By:
Pageof 43
Neuroscience Letters|May 4, 2019
Using spatial frequency scales for processing own-race and other-race faces: An ERP analysisQizhi Yao, Lun ZhaoResearch Initiative, Treatment Action : RITA|July 9, 2003
Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particlesQizhi YaoLaboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2002
HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cellsZeguang Ren, Qizhi Yao, Changyi ChenCurrent Vascular Pharmacology|July 16, 2009
Ginseng compounds: an update on their molecular mechanisms and medical applicationsJian-Ming Lü, Qizhi Yao, Changyi ChenMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 18, 2016
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An OverviewChangyi Chen, Jian-Ming Lü, Qizhi YaoBiochemical Pharmacology|September 3, 2013
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and goutJian-Ming Lü, Qizhi Yao, Changyi ChenCancer Biology & Therapy|January 17, 2007
Colorectal cancer: new advances in immunotherapyRafael Cubas, Min Li, Changyi Chen, et al.Cancer Biology & Therapy|December 22, 2009
ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenograftsYuqing Zhang, Changyi Chen, Qizhi Yao, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 31, 2008
Roles and mechanisms of copper transporting ATPases in cancer pathogenesisYuqing Zhang, Min Li, Qizhi Yao, et al.Thrombosis Research|October 24, 2007
C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cellsChangyi Chen, Bicheng Nan, Peter Lin, et al.Pageof 43